HideChilds = False
SystemName = Homepage
 

Bioverativ – Science matters. Because patients matter.

Science Matters.
Because Patients Matter.

An Open Letter to the Canadian Hemophilia Community on the Continued Availability of Eloctate® and Alprolix®

Learn more
 

Science that redefines what's possible

Our scientists brought the first major advances in hemophilia treatment in nearly two decades, and we’re committed to developing new, life-changing medicines for people with rare blood disorders.

Learn more
 

Guided by our dedication to community

Working in partnership with patients, physicians, caregivers, and advocates, we aim to improve access to treatment, advance disease understanding and transform lives.

Learn more
 

Bioverativ (a Sanofi company) in the news

June 18, 2018 2:30 AM

Cold Agglutinin Disease Associated with Greater Than Twofold Increased Risk of Mortality in First Five Years After Diagnosis

Read more